Biosimilars

Biosimilars

  • $9.99


As many biological products face losing their patents in the next decade, the pharmaceutical industry needs an abbreviated regulatory pathway for approval of biosimilar drug products, which are cost-effective, follow-on/subsequent versions of the innovator�s biologic products.

en English
en Englishpt Portuguesees Spanish